Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Centessa Pharmaceuticals plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Centessa Pharmaceuticals plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Medicxi Growth I LP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Growth Co-Invest I LP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Ventures Management (Jersey) Ltd | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Growth I GP Ltd | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Ventures I GP Ltd | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Ventures I LP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Co-Invest I LP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Secondary I LP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Secondary I GP Ltd. | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Medicxi Secondary Co-Invest I LP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Index Ventures Life VI (Jersey) L.P. | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Yucca (Jersey) SLP | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Index Venture Life Associates VI Ltd | 10% Owner | 0Indirect | Jun 24, 2026 | 1 |
| Hedley Mary Lynne | Director | – | Jun 24, 2026 | 1 |
| Zbar Brett I W | Director | – | Jun 24, 2026 | 1 |
| Weinhoff Gregory M | Chief Business Officer | 0 | Jun 24, 2026 | 4 |
| Crowley John J | Chief Financial Officer | 0 | Jun 24, 2026 | 2 |
| De Rubertis Francesco | Director | 0Indirect | Jun 24, 2026 | 1 |
| Kanes Stephen | Chief Medical Officer | 0 | Jun 24, 2026 | 2 |
| Kulkarni Samarth | Director | – | Jun 24, 2026 | 1 |
| Anderson Karen M. | Chief People Officer | 0 | Jun 24, 2026 | 5 |
| Goyal Arjun | Director | 0Indirect | Jun 24, 2026 | 1 |
| Hussain Iqbal J | Chief Legal Officer | 0Indirect | Jun 24, 2026 | 4 |
| Stuckley Carol | Director | – | Jun 24, 2026 | 1 |
| Bush Tia L | Chief Technology & Quality Ofc | 0 | Jun 24, 2026 | 4 |
| Hukkelhoven Mathias | Director | – | Jun 24, 2026 | 1 |
| Deferiere Raphael | Chief Accounting Officer | 0 | Jun 24, 2026 | 2 |
| Accardi Mario Alberto | Chief Executive Officer | 0 | Jun 24, 2026 | 7 |
| Saha Saurabh | Chief Executive Officer | 221,017 | Jul 21, 2025 | 0 |
| Chao David M | Chief Administrative Officer | 225,007 | Mar 19, 2025 | 0 |
| Rotman Harris | SVP Regulatory Affairs | 62,625 | Feb 2, 2024 | 0 |
| Grainger David J | Chief Innovation Officer | 962,790 | Jan 2, 2024 | 0 |
| GAP (Bermuda) L.P. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic Genpar (Bermuda), L.P. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic Partners (Bermuda) EU, L.P. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic Partners (Bermuda) IV, L.P. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic Partners (Lux), SCSp | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic GenPar (Lux) SCSp | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic (Lux) S.a r.l. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic UM B.V. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic Cooperatief U.A. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| General Atlantic Cooperatief, L.P. | Director, 10% Owner | – | Jun 26, 2023 | 0 |
| Yver Antoine | EVP & Chairman of Development | 783,066 | Jun 2, 2023 | 0 |
| Templeman Thomas | Chief Technology Officer | 188,244 | Apr 4, 2023 | 0 |
| Shahidi Javad | Chief Medical Officer | 165,000 | Nov 23, 2022 | 0 |
| Thorell Marella | Chief Accounting Officer | 53,101 | Mar 23, 2022 | 0 |
| Kantoff Aaron | Director | 60,000 | Nov 18, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Saha SaurabhChief Executive Officer | PPurchase | +23.0K | $12.28 | +$282.4K | New position23.0K after | |
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Bush Tia LChief Quality Officer | PPurchase | +5.00K | $12.46 | +$62.3K | +166.7%8.00K after | 2 lots |
| Nov 18, 2021 (view filing) | Nov 18 | Same day | Kantoff AaronDirector | PPurchase | +10.0K | $11.99 | +$119.9K | +20.0%60.0K after | |
| Nov 30, 2021 (view filing) | Nov 26-29 | 4 days | De Rubertis FrancescoDirector | PPurchase | +68.5K | $11.64 | +$797.5K | +312.1%90.5K after | 4 lots |
| Nov 30, 2021 (view filing)5:11 PM ET | Nov 26-29 | 4 days | Medicxi Growth I LP and 3 others10% Owner | PPurchase | +68.5K | $11.64 | +$797.4K | +312.1%90.5K after | 4 lots |
| Dec 2, 2021 (view filing) | Nov 30-Dec 1 | 2 days | De Rubertis FrancescoDirector | PPurchase | +97.2K | $12.24 | +$1.19M | New position92.7K after | 4 lots |
| Dec 2, 2021 (view filing)5:10 PM ET | Nov 30-Dec 1 | 2 days | Medicxi Growth I LP and 3 others10% Owner | PPurchase | +97.2K | $12.24 | +$1.19M | New position92.7K after | 4 lotsDuplicate filing |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | De Rubertis FrancescoDirector | PPurchase | +34.3K | $12.82 | +$440.1K | +58.0%93.5K after | 2 lots |
| Dec 6, 2021 (view filing)5:11 PM ET | Dec 2 | 4 days | Medicxi Growth I LP and 3 others10% Owner | PPurchase | +34.3K | $12.82 | +$440.1K | +58.0%93.5K after | 2 lotsDuplicate filing |
| Feb 1, 2022 (view filing) | Jan 28 | 4 days | Grainger David JChief Innovation Officer | PPurchase | +27.5K | $9.05 | +$248.9K | New position27.5K after | |
| Feb 4, 2022 (view filing) | Feb 2 | 2 days | Saha SaurabhChief Executive Officer | PPurchase | +5.00K | $9.74 | +$48.7K | +21.7%28.0K after | |
| May 19, 2022 (view filing) | May 17-18 | 2 days | Yver AntoineEVP & Chairman of Development | SSale | −85.0K | $5.18 | −$440.0K | −10.2%748.9K after | 2 lots |
| Jun 21, 2022 (view filing) | Jun 17 | 4 days | Yver AntoineEVP & Chairman of Development | SSale | −9.20K | $4.68 | −$43.1K | −1.2%739.7K after | |
| Jun 27, 2022 (view filing) | Jun 24 | 3 days | Saha SaurabhChief Executive Officer | PPurchase | +10.0K | $4.63 | +$46.3K | +35.7%38.0K after | |
| Jul 6, 2022 (view filing) | Jul 1 | 5 days | Yver AntoineEVP & Chairman of Development | SSale | −9.10K | $5.03 | −$45.8K | −1.2%730.6K after | |
| Jul 20, 2022 (view filing) | Jul 18 | 2 days | Yver AntoineEVP & Chairman of Development | SSale | −20.0K | $4.87 | −$97.4K | −2.4%810.6K after | |
| Aug 3, 2022 (view filing) | Aug 1 | 2 days | Yver AntoineEVP & Chairman of Development | SSale | −10.4K | $4.45 | −$46.4K | −1.3%800.2K after | |
| Sep 2, 2022 (view filing) | Sep 1 | 1 day | Yver AntoineEVP & Chairman of Development | SSale | −10.4K | $4.41 | −$46.0K | −1.3%789.8K after | |
| Oct 4, 2022 (view filing) | Sep 30 | 4 days | Yver AntoineEVP & Chairman of Development | SSale | −2.47K | $4.07 | −$10.0K | −0.3%787.3K after | From original |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Yver AntoineEVP & Chairman of Development | SSale | −9.70K | $4.03 | −$39.1K | −1.3%765.1K after | |
| Nov 23, 2022 (view filing) | Oct 3 | 51 days | Yver AntoineEVP & Chairman of Development | SSale | −9.50K | $3.91 | −$37.1K | −1.2%780.3K after | Amended |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | Yver AntoineEVP & Chairman of Development | SSale | −9.40K | $3.91 | −$36.8K | −1.2%761.2K after | |
| Jan 4, 2023 (view filing) | Jan 4 | Same day | Yver AntoineEVP & Chairman of Development | SSale | −6.97K | $3.18 | −$22.2K | −0.9%751.9K after | |
| Feb 3, 2023 (view filing) | Feb 1 | 2 days | Yver AntoineEVP & Chairman of Development | SSale | −7.70K | $3.79 | −$29.2K | −0.9%813.7K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Yver AntoineEVP & Chairman of Development | SSale | −7.00K | $3.42 | −$23.9K | −0.9%806.7K after | |
| Apr 4, 2023 (view filing) | Apr 3 | 1 day | Yver AntoineEVP & Chairman of Development | SSale | −6.70K | $3.69 | −$24.7K | −0.8%796.4K after | 10b5-1 |
| May 2, 2023 (view filing) | May 1 | 1 day | Yver AntoineEVP & Chairman of Development | SSale | −6.80K | $4.42 | −$30.1K | −0.9%789.6K after | 10b5-1 |
| May 26, 2023 (view filing) | May 24 | 2 days | Bush Tia LChief Quality Officer | SSale | −8.00K | $4.49 | −$35.9K | −100.0%0 after | 2 lots |
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | Yver AntoineEVP & Chairman of Development | SSale | −6.50K | $4.45 | −$28.9K | −0.8%783.1K after | 10b5-1 |
| Sep 22, 2023 (view filing) | Sep 20 | 2 days | Rotman HarrisSVP Regulatory Affairs | SSale | −37.5K | $6.29 | −$235.8K | −52.8%33.5K after | 10b5-1 |
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Rotman HarrisSVP Regulatory Affairs | SSale | −4.27K | $8.10 | −$34.6K | −6.4%62.6K after | 10b5-1 |
| Mar 26, 2024 (view filing) | Mar 25 | 1 day | Anderson Karen M.Chief People Officer | SSale | −51.2K | $11.89 | −$608.2K | −41.7%71.5K after | 2 lots10b5-1 |
| Aug 22, 2024 (view filing) | Aug 20-22 | 2 days | Saha SaurabhChief Executive Officer | SSale | −8.35K | $12.28 | −$102.6K | −1.0%823.6K after | 3 lots10b5-1 |
| Aug 23, 2024 (view filing) | Aug 22-23 | 1 day | Weinhoff Gregory MChief Business Officer | SSale | −30.0K | $12.24 | −$367.2K | −11.8%223.4K after | 2 lots10b5-1 |
| Aug 23, 2024 (view filing) | Aug 23 | Same day | Saha SaurabhChief Executive Officer | SSale | −46.7K | $12.30 | −$573.8K | −5.7%776.9K after | 10b5-1 |
| Sep 9, 2024 (view filing) | Sep 9 | Same day | Weinhoff Gregory MChief Business Officer | SSale | −25.0K | $15.00 | −$375.0K | −10.1%223.4K after | 10b5-1 |
| Sep 12, 2024 (view filing) | Sep 10 | 2 days | Saha SaurabhChief Executive Officer | SSale | −175.0K | $16.52 | −$2.89M | −18.4%776.9K after | 10b5-1 |
| Sep 12, 2024 (view filing) | Sep 10 | 2 days | Weinhoff Gregory MChief Business Officer | SSale | −30.0K | $17.00 | −$510.0K | −11.8%223.4K after | 10b5-1 |
| Sep 20, 2024 (view filing) | Sep 20 | Same day | Saha SaurabhChief Executive Officer | SSale | −55.0K | $16.53 | −$909.1K | −7.1%721.9K after | 10b5-1 |
| Sep 27, 2024 (view filing) | Sep 25 | 2 days | Weinhoff Gregory MChief Business Officer | SSale | −16.6K | $15.69 | −$260.8K | −7.4%206.8K after | 10b5-1 |
| Oct 23, 2024 (view filing) | Oct 21-23 | 2 days | Saha SaurabhChief Executive Officer | SSale | −55.0K | $15.71 | −$863.8K | −8.0%630.7K after | 3 lots10b5-1 |
| Oct 25, 2024 (view filing) | Oct 25 | Same day | Weinhoff Gregory MChief Business Officer | SSale | −11.7K | $15.38 | −$180.6K | −6.0%183.3K after | 10b5-1 |
| Nov 15, 2024 (view filing) | Nov 13 | 2 days | Saha SaurabhChief Executive Officer | SSale | −32.0K | $18.28 | −$585.4K | −4.8%630.7K after | 10b5-1 |
| Nov 22, 2024 (view filing) | Nov 20-22 | 2 days | Saha SaurabhChief Executive Officer | SSale | −60.2K | $17.01 | −$1.02M | −9.5%575.7K after | 3 lots |
| Nov 27, 2024 (view filing) | Nov 25 | 2 days | Weinhoff Gregory MChief Business Officer | SSale | −10.0K | $17.66 | −$176.6K | −5.2%183.3K after | 10b5-1 |
| Nov 27, 2024 (view filing) | Nov 25 | 2 days | Saha SaurabhChief Executive Officer | SSale | −299 | $18.23 | −$5.45K | −0.1%575.7K after | 10b5-1 |
| Dec 6, 2024 (view filing) | Dec 6 | Same day | Saha SaurabhChief Executive Officer | SSale | −87.5K | $18.46 | −$1.62M | −13.2%575.7K after | 10b5-1 |
| Dec 17, 2024 (view filing) | Dec 13-17 | 4 days | Anderson Karen M.Chief People Officer | SSale | −16.5K | $17.21 | −$284.0K | −18.7%71.5K after | 2 lots10b5-1 |
| Dec 17, 2024 (view filing) | Dec 16 | 1 day | Hussain Iqbal JGeneral Counsel | SSale | −77.7K | $16.39 | −$1.27M | −38.2%125.8K after | 10b5-1 |
| Dec 17, 2024 (view filing) | Dec 16-17 | 1 day | Bush Tia LChief Technology & Quality Ofc | SSale | −27.4K | $17.43 | −$477.9K | −15.7%147.6K after | 2 lots10b5-1 |